Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Dec;24(6):611-35.
doi: 10.1007/BF02353483.

Characterization of four basic models of indirect pharmacodynamic responses

Affiliations

Characterization of four basic models of indirect pharmacodynamic responses

A Sharma et al. J Pharmacokinet Biopharm. 1996 Dec.

Abstract

Four basic models of indirect pharmacodynamic responses were characterized in terms of changing dose, Imax or Smax, and IC50 or SC50 to examine the effects of these fundamental drug properties on response profiles. Standard pharmacokinetic parameters were used for generating plasma concentration, and response-time profiles using computer simulations. Comparisons to theoretical expectations were made. In all four models, the maximum response (Rmax) (inhibition or stimulation) and the time of its occurrence (TRmax) were dependent on the model, dose, Imax or Smax, and IC50 or SC50 values. An increase in dose or a decrease in IC50 or SC50 by the same factor produced, as theoretically expected, identical and superimposable pharmacodynamic response patterns in each of the models. Some parameters (TRmax, ABEC) were nearly proportional to log dose, while others (Rmax, CRmax) were nonlinear. Assessment of expected response signature patterns as demonstrated in this report may be helpful in experimental designs and in assigning appropriate models to pharmacodynamic data.

PubMed Disclaimer

References

    1. J Pharm Sci. 1998 Jan;87(1):67-72 - PubMed
    1. Clin Pharmacol Ther. 1993 Oct;54(4):402-14 - PubMed
    1. J Pharmacokinet Biopharm. 1994 Dec;22(6):469-80 - PubMed
    1. J Pharmacokinet Biopharm. 1995 Feb;23(1):5-8; discussion 9-10 - PubMed
    1. Clin Pharmacol Ther. 1994 Oct;56(4):406-19 - PubMed

Publication types